Loading clinical trials...
Loading clinical trials...
Botulinum Neurotoxin for Children With Cerebral Palsy: a Delicate Balance Between Clinical Benefits and Muscular Harm
Conditions
Locations
1
Belgium
UZ Leuven
Leuven, Vlaams-Brabant, Belgium
Start Date
February 3, 2025
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2028
Last Updated
February 10, 2026
NCT07403162
NCT06598657
NCT06930963
NCT06785220
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions